Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer

Digestive Diseases and Sciences

Volumn 54, Issue 6, 2009, Pages 1203-1207

  Dragutinovic V ^a   Izrael Zivkovic L ^a   Radovanovic N ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Gastric cancer; Gelatinases; Matrix metalloproteinases; Proteolytic activity

Indexed keywords

GELATINASE B; PROTEINASE;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LYMPH VESSEL; MALE; MEMBRANE DAMAGE; METASTASIS; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CANCER; TUMOR CELL; ZYMOGRAPHY;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 67349254117     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0472-y     Document Type: Article

References (31)

1. T Itoh M Tanioka H Yoshida T Yoshioka H Nishimoto S Itohara 1998 Reduced angiogenesis and tumor progression in gelatinase A - deficient mice Cancer Res 58 1048 1051 (Pubitemid 28182477)
2. LA Liotta 1986 Tumor invasion and metastases: role of the extracellular matrix: Rhoads memorial award lecture Cancer Res 46 1 7 10.1016/S0065-230X(08) 60034-2 (Pubitemid 16189019)
3. LA Liotta K Tryggvason S Garbis I Hart CM Foltz S Shafie 1980 Metastatic potential correlates with enzymatic degradation of basement membrane collagen Nature 284 67 68 10.1038/284067a0 (Pubitemid 10098769)
4. LJ Mc Cawley LM Matrisian 2000 Matrix metalloproteinases: multifunctional contributors to tumor progression Mol Med Today 6 4 149 156 10.1016/S1357-4310(00)01686-5 (Pubitemid 30171365)
5. S Zucker RM Lysik MH Zarrabi U Moll 1993 M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer Cancer Res 53 140 146 (Pubitemid 23019389)
6. S Hoikkala P Paakko Y Soini R Makitaro V Kinnula T Turpeenniemi-Hujanen 2005 Tissue MMP-2/TIMP-2-complex are better prognostic factors than serum MMP-2, MMP-9 or TIMP-1 in stage I-III lung carcinoma Cancer Lett 236 125 132 10.1016/j.canlet.2005.05.012
7. H Ruokolainen P Paakko T Turpeenniemi-Hujanen 2005 Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker Int J Cancer 116 422 427 10.1002/ijc.21092 (Pubitemid 40993339)
8. KH Shen CW Chi SS Lo HL Kao WY Lui CW Wu 2000 Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer Anticancer Res 20 1307 1310 (Pubitemid 30240719)
9. A Hayasaka N Suzuki N Fujimoto 1996 Elevated plasma levels of matrix metalloproteinase-9 (92 kDa type IV collagenase/gelatinase B) in hepatocellular carcinoma Hepatology 24 1058 1062 10.1002/hep.510240513 (Pubitemid 26365903)
10. K Endo Y Maehara H Baba M Yamamoto S Tomisaki A Watanabe 1997 Elevated levels of serum and plasma metalloproteinases in patient with gastric cancer Anticancer Res 17 2253 2255 (Pubitemid 27320978)
11. A Torii Y Kodera K Uesaka T Kiarai K Yasni T Morimoto 1997 Plasma concentration of matrix metalloproteinase 9 in gastric cancer Br J Surg 84 133 136 10.1002/bjs.1800840147 (Pubitemid 27033129)
12. CD Souza-Tarla JA Uzuelli AA Machado RF Gerlach JE Tanus-Santos 2005 Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activites Clin Biochem 38 5 410 414 10.1016/j.clinbiochem.2005.02.010 (Pubitemid 40501523)
13. RF Gerlach JA Uzuelli CD Souza-Tarla JE Tanus-Santos 2005 Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activites Anal Biochem 344 1 147 149 10.1016/j.ab.2005.04.038 (Pubitemid 41569391)
14. RF Gerlach C Demacq K Jung JE Tanus-Santos 2007 Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma Clin Biochem 40 1-2 119 123 10.1016/j.clinbiochem.2006.10. 007 (Pubitemid 46014168)
15. F Manello JE Tanus-Santos CA Meschiari GA Tonti 2008 Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices Anal Biochem 374 56 63 10.1016/j.ab.2007.11.020
16. W Ebeling N Hennrich M Klockow H Metz HD Orth H Lang 1974 Protenase K from Tritirachium album Eur J Biochem 47 91 97 10.1111/j.1432-1033.1974.tb03671. x
17. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 10.1038/227680a0
18. DE Kleiner WG Stetler-Stevenson 1994 Quantative zymography detection of picogram quantities of gelatinases Anal Biochem 218 325 329 10.1006/abio.1994. 1186 (Pubitemid 24141631)
19. AG Gornall CJ Bardawill MM David 1949 Determination of serum proteins by means of the Biuret reaction J Biol Chem 177 751 766
20. Aznovoorian S, Murphy AN, Stettler-Stevenson WG, Liotta LA. Molecular aspects of tumor cells invasion and metastasis. Cancer. 1993;71:1368-1383. doi :10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L.
21. H Nagase JF Woessner Jr 1999 Matrix metalloproteinases J Biol Chem 274 21491 21494 10.1074/jbc.274.31.21491 (Pubitemid 29359963)
22. J Westermarck VM Kahari 1999 Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 781 792 (Pubitemid 29220691)
23. V Ellenrieder G Adler TM Gress 1999 Invasion and metastasis in pancreatic cancer Ann Oncol 10S 45 50 (Pubitemid 29333394)
24. BV Kallakury S Karikehalli A Haholu CE Sheehan N Azumi JS Ross 2001 Increased expression of matrix metalloproteinases 2 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma Clin Cancer Res 7 3113 31199 (Pubitemid 32963832)
25. CF Sier FJ Kubben S Ganesh MM Heerding G Griffioen R Hanemaaijer 1996 Tissue levels of matrix metalloproteinases MMP-2 and MMP 9 are related to the overall survival of patients with gastric carcinoma Br J Cancer 74 413 417 (Pubitemid 26254571)
26. A Kabashima Y Maehara Y Kakeji H Baba T Koga K Sugimachi 2000 Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis Clin Cancer Res 6 3581 3584
27. M Paez Preda MF Ledda V Goldberg A Chervin G Carrizo H Molina 2000 High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells J Clin Endocrinol Metab 85 263 10.1210/jc.85.1.263 (Pubitemid 32268824)
28. FJGM Kubben CFM Sier W van Duijn G Griffioen R Hanemaaijer CJH van de Velde 2006 Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer Br J Cancer 94 1035 1040 10.1038/sj.bjc.6603041
29. CY Wu MS Wu EP Chiang YJ Chen CJ Chen NH Chi 2007 Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution Clin Cancer Res 13 7 2054 2060 10.1158/1078-0432.CCR-06-2299 (Pubitemid 46649872)
30. MW Kattan 2003 Judging new markers by their ability to improve predictive accuracy J Natl Cancer Inst 95 634 635 (Pubitemid 36603708)
31. MW Kattan MS Karpeh M Mazymdar MF Brennan 2003 Postoperative nonogram for disease-specific survival after an RO resection for gastric cancer carcinoma J Clin Oncol 21 3647 3650 10.1200/JCO.2003.01.240 (Pubitemid 46594058)